As of September 2023 GlaxoSmithKline has a market cap of $75.34 Billion. This makes GlaxoSmithKline the world's 178th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $75.34 B | 4.74% |
2022 | $71.93 B | -34.07% |
2021 | $109.10 B | 18.9% |
2020 | $91.76 B | -21.15% |
2019 | $116.38 B | 23.9% |
2018 | $93.93 B | 6.6% |
2017 | $88.11 B | -6.48% |
2016 | $94.22 B | -4.88% |
2015 | $99.05 B | -4.91% |
2014 | $104.16 B | -19.26% |
2013 | $129.00 B | 21.97% |
2012 | $105.76 B | -8.18% |
2011 | $115.19 B | 13.05% |
2010 | $101.89 B | -7.08% |
2009 | $109.65 B | 13.45% |
2008 | $96.66 B | -30.35% |
2007 | $138.78 B | -8.6% |
2006 | $151.83 B | 3.03% |
2005 | $147.36 B | 4.74% |
2004 | $140.69 B | 6.84% |
2003 | $131.68 B | 16.71% |
2002 | $112.83 B | -26.62% |
2001 | $153.76 B |
On Sep 29th, 2023 the market cap of GlaxoSmithKline was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $210.67 B | 179.62% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $187.27 B | 148.56% | ๐บ๐ธ USA |
![]() Sanofi SNY | $136.32 B | 80.94% | ๐ซ๐ท France |
![]() Merck MRK | $261.23 B | 246.73% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $210.58 B | 179.51% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $11.43 B | -84.83% | ๐ฎ๐ฑ Israel |
![]() Dynavax Technologies
DVAX | $1.90 B | -97.48% | ๐บ๐ธ USA |